Old Web
English
Sign In
Acemap
>
Paper
>
1043P NF1 mutations and immune checkpoint inhibitor outcomes in patients with BRAF wildtype melanoma
1043P NF1 mutations and immune checkpoint inhibitor outcomes in patients with BRAF wildtype melanoma
2021
M. Vilbert
A. Rose
L. Mantle
I King
T. Pimentel Muniz
Sofia Genta
Diana Paola Arteaga
R. Singh
Z. Saeed Kamil
Marcus O. Butler
Samuel Saibil
Alexandra M. Easson
A Covelli
David W. Hogg
Anna Spreafico
Keywords:
Cancer research
Melanoma
Wild type
in patient
immune checkpoint inhibitors
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]